Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Blood (2013) 121 (20): 4021–4031.

https://doi.org/10.1182/blood-2012-10-460063

Published: 2013

Includes: Supplemental data

Journal Articles

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Blood (2013) 121 (14): 2715–2724.

https://doi.org/10.1182/blood-2012-10-461848

Published: 2013

Includes: Supplemental data

Journal Articles

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Blood (2012) 120 (19): 3986–3996.

https://doi.org/10.1182/blood-2012-05-433334

Published: 2012

Includes: Supplemental data

Journal Articles

Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome

Ken I. Mills, Alexander Kohlmann, P. Mickey Williams, Lothar Wieczorek, Wei-min Liu, Rachel Li, Wen Wei, David T. Bowen, Helmut Loeffler, Jesus M. Hernandez, Wolf-Karsten Hofmann, Torsten Haferlach

Blood (2009) 114 (5): 1063–1072.

https://doi.org/10.1182/blood-2008-10-187203

Published: 2009

Includes: Supplemental data

Journal Articles

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

Blood (2008) 112 (11): 753.

https://doi.org/10.1182/blood.V112.11.753.753

Published: 2008

Journal Articles

Intraplatform Reproducibility and Technical Precision of Gene Expression Profiling in Four Laboratories Investigating 112 Leukemia Samples: The DACH Study.

Alexander Kohlmann, PhD, Elisabeth Haschke-Becher, MD, Barbara Wimmer, PhD, Ariana Huber-Wechselberger, PhD, Sandrine Meyer-Monard, MD, Heike Huxol, Uwe Siegler, PhD, Michel Rossier, PhD, Thomas Matthes, MD, Michela Rebsamen, PhD, Adeline Diemand, Alberto Chiappe, Sonja Rauhut, Wei-min Liu, PhD, Andrea Johnson, PhD, Lothar Wieczorek, PhD, Torsten Haferlach, MD

Blood (2007) 110 (11): 2383.

https://doi.org/10.1182/blood.V110.11.2383.2383

Published: 2007

Journal Articles

Microarray Classification of Myelodysplastic Syndrome (MDS) Identifies Subgroups with Distinct Clinical Outcomes.

Ken I. Mills, PhD, Alex Kohlmann, Ph.D., Mickey Williams, Ph.D., Wei-Min Liu, Ph.D., Rachel Li, David T. Bowen, M.D., Helmut Loeffler, M.D., Jesus M. Hernandez, M.D., Wolf-Karsten Hofmann, M.D., Torsten Haferlach, M.D., Lothar Wieczirek, Ph.D.

Blood (2007) 110 (11): 2426.

https://doi.org/10.1182/blood.V110.11.2426.2426

Published: 2007

Journal Articles

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

Blood (2007) 110 (11): 3169.

https://doi.org/10.1182/blood.V110.11.3169.3169

Published: 2007

Journal Articles

An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy.

Blood (2006) 108 (11): 103.

https://doi.org/10.1182/blood.V108.11.103.103

Published: 2006

Journal Articles

Development of a Robust and User-Friendly Method for Leukemia Classification Using Microarrays.

Wen Wei, PhD, Julie Tsai, Barbara Brady, Wei-min Liu, PhD, Xiaoying Chen, Rui Li, Sunhee Ro, PhD, James Sun, Alexander Kohlmann, PhD, Stuart Palmer, PhD, Raymond Wong, Khusbeer Malhotra, PhD, James Novotny, PhD, Mickey Williams, PhD

Blood (2006) 108 (11): 4304.

https://doi.org/10.1182/blood.V108.11.4304.4304

Published: 2006

Journal Articles

New Data on Robustness of Gene Expression Signatures in Leukemia: Comparison of Three Distinct Total RNA Preparation Procedures.

Marta Campo, Dell’Orto Graduate, Andrea Zangrando, Graduate, Luca Trentin, Graduate, Rui Li, PhD, Wei-min Liu, PhD, Geertruy te Kronnie, PhD, Giuseppe Basso, MD, Alexander Kohlmann, PhD

Blood (2006) 108 (11): 4288.

https://doi.org/10.1182/blood.V108.11.4288.4288

Published: 2006

Journal Articles

B-Cell Scaffold Protein with Ankyrin Repeats (BANK1) Is Differentially Expressed in ZAP-70 Negative Compared to ZAP-70 Positive Chronic Lymphocytic Leukemia Cells.

Frank Dicker, Susanne Schnittger, Claudia Schoch, Alexander Kohlmann, Wei-Min Liu, Wolfgang Kern, Torsten Haferlach Prof

Blood (2005) 106 (11): 2938.

https://doi.org/10.1182/blood.V106.11.2938.2938

Published: 2005

Journal Articles

A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling.

Torsten Haferlach, MD, Alexander Kohlmann, PhD, Guiseppe Basso, PhD, Marie-Christine Bene, PhD, James R. Downing, PhD, Jesus M. Hernandez, MD, Wolf-Karsten Hofmann, MD, Thomas J. Kipps, PhD, Truus te Kronnie, PhD, Wei-Min Liu, Sunhee Ro, Elisabeth MacIntyre, PhD, Ken I. Mills, PhD, Claude Preudhomme, PhD, Laura Z. Rassenti, PhD, John de Vos, PhD, Mickey Williams, PhD, Lothar Wieczorek, Robin Foa, PhD

Blood (2005) 106 (11): 757.

https://doi.org/10.1182/blood.V106.11.757.757

Published: 2005

NARROW

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

Intraplatform Reproducibility and Technical Precision of Gene Expression Profiling in Four Laboratories Investigating 112 Leukemia Samples: The DACH Study.

Microarray Classification of Myelodysplastic Syndrome (MDS) Identifies Subgroups with Distinct Clinical Outcomes.

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy.

Development of a Robust and User-Friendly Method for Leukemia Classification Using Microarrays.

New Data on Robustness of Gene Expression Signatures in Leukemia: Comparison of Three Distinct Total RNA Preparation Procedures.

B-Cell Scaffold Protein with Ankyrin Repeats (BANK1) Is Differentially Expressed in ZAP-70 Negative Compared to ZAP-70 Positive Chronic Lymphocytic Leukemia Cells.

A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only